Zobrazeno 1 - 4
of 4
pro vyhledávání: '"F D Tattersall"'
Publikováno v:
British Journal of Pharmacology. 157:865-880
Nausea and vomiting are among the most common symptoms encountered in medicine as either symptoms of disease or side effects of treatments. Developing novel anti-emetics and identifying emetic liability in novel chemical entities rely on models that
Autor:
Neil Collinson, B. J. Everitt, Guy R. Seabrook, Keith A. Wafford, F. D. Tattersall, David S. Reynolds, M. Cobain, W. Rycroft, Angus Murray Macleod, Hedaythul Choudhury, John R. Atack, Goplan V. Pillai, Gerard R. Dawson, L. M. McDonald, Alison J. Smith, F. Sternfeld, Karen A. Maubach
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 316:1335-1345
Alpha5IA is a compound that binds with equivalent subnanomolar affinity to the benzodiazepine (BZ) site of GABA(A) receptors containing an alpha1, alpha2, alpha3, or alpha5 subunit but has inverse agonist efficacy selective for the alpha5 subtype. As
Autor:
L. Singh, Linda J. Bristow, Paul D. Leeson, Brian John Williams, Peter H. Hutson, Mark D. Tricklebank, F. D. Tattersall, Michael Rowley, L. Thorn, K. L. Saywell
Publikováno v:
British Journal of Pharmacology. 113:729-736
1. The anticonvulsant and behavioural effects of the glycine/NMDA receptor partial agonist, L-687,414 (R(+)-cis-beta-methyl-3-amino-1-hydroxypyrrolid-2-one) have been investigated in rodents. 2. L-687,414 dose-dependently antagonized seizures induced
Publikováno v:
Psychopharmacology. 197(4)
Rationale Tiagabine is an anticonvulsant drug which may also have sleep-enhancing properties. It acts by inhibiting reuptake at the gamma-aminobutyric acid (GABA) transporter (GAT-1). Objectives The aim of the study was to determine whether tiagabine